Recent advances in the diagnosis of adenocarcinoma: The impact of lung cancer screening on histopathologists

Current Diagnostic Pathology

Volumn 10, Issue 4, 2004, Pages 269-278

  Flieder, D B ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Bronchioloalveolar carcinoma; High resolution computed tomography; Lung adenocarcinoma

Indexed keywords

ASPIRATION BIOPSY; CANCER CELL; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONFERENCE PAPER; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMMUNOHISTOCHEMISTRY; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG METASTASIS; METASTASIS; PATHOLOGIST; PROGNOSIS; TRANSBRONCHIAL BIOPSY; WORLD HEALTH ORGANIZATION;

EID: 3042798020     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cdip.2004.03.002     Document Type: Conference Paper

References (48)

1. Boyle P., d'Onofrio A., Maisonneuve P., et al. Measuring progress against cancer in Europe. has the 15% decline targeted for 2000 come about? Ann Oncol. 14:2003;1312-1325
2. Janssen-Heijnen M.L., Coebergh J.W. The changing epidemiology of lung cancer in Europe. Lung Cancer. 41:2003;245-258
3. Henschke C.I., McCauley D.I., Yankelevitz D.F., et al. Early lung cancer action program. overall design and findings from baseline screening Lancet. 354:1999;99-105
4. McKenna R.J., Wolf R.K., Brenner M., et al. Is lobectomy by video-assisted thoracic surgery an adequate cancer operation? Ann Thorac Surg. 66:1998;1903-1908
5. Kaneko M., Eguchi K., Ohmatsu H., et al. Peripheral lung cancer. screening and detection with low-dose spiral CT versus radiography Radiology. 201:1996;798-802
6. Swenson S.J., Jett J.R., Sloan J.A., et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med. 165:2002;508-513
7. Koike T., Yamato Y., Yoshiya K., et al. Criteria for intentional limited pulmonary resection in cT1N0M0 peripheral lung cancer. Jpn J Thorac Cardiovasc Surg. 51:2003;515-519
8. Travis W.D., Colby T.V., Corrin B., et al. Histological typing of lung and pleural tumours. World Health Organization International Histological Classification of Tumours. 3rd ed.):1999;Springer, Berlin
9. Amin M.B., Tamboli P., Merchant S.H., et al. Micropapillary component in lung adenocarcinoma. a distinctive histologic feature with possible prognostic significance Am J Surg Pathol. 26:2002;358-364
10. Miyoshi T., Satoh Y., Okumura S., et al. Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis. Am J Surg Pathol. 27:2003;101-109
11. Liebow A.A. Bronchiolo-alveolar carcinoma. Adv Intern Med. 10:1960;329-358
12. Nomori H., Ohtsuka T., Naruke T., Suemasu K. Histogram analysis of computed tomography numbers of clinical T1 N0 M0 lung adenocarcinoma, with special reference to lymph node metastasis and tumor invasiveness. J Thorac Cardiovasc Surg. 126:2003;1584-1589
13. Matsuguma H., Yokoi K., Anraku M., et al. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1N0M0 adenocarcinoma of the lung. a predictor of lymph node metastasis J Thorac Cardiovasc Surg. 124:2002;278-284
14. Aoyagi Y., Yokose T., Minami Y., et al. Accumulation of losses of heterozygosity and multistep carcinogenesis in pulmonary adenocarcinoma. Cancer Res. 61:2001;7950-7954
15. Koga T., Hashimoto S., Sugio K., et al. Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma. Clin Cancer Res. 7:2001;1730-1738
16. Ito A., Okada M., Uchino K., et al. Expression of the TSLC1 adhesion molecule in pulmonary epithelium and its down-regulation in pulmonary adenocarcinoma other than bronchioloalveolar carcinoma. Lab Invest. 83:2003;1175-1183
17. Rena O., Papalia E., Ruffini E., et al. Stage I pure bronchioloalveolar carcinoma. recurrences, survival and comparison with adenocarcinoma of the lung Eur J Cardiothorac Surg. 23:2003;409-414
18. Flieder D.B., Vazquez M., Carter D., et al. Baseline lung cancers in the early lung cancer action program (ELCAP). pathologic features and expert panel findings [abstract] Mod Pathol. 16:2003;306A
19. Yousem S.A., Finkelstein S.D., Swalsky P.A., et al. Absence of jaagsiekte sheep retrovirus DNA and RNA in bronchiolalveolar and conventional human pulmonary adenocarcinoma by PRC and RT-PCR analysis. Hum Pathol. 32:2001;1039-1042
20. Noguchi M., Morikawa A., Kawasaki M., et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer. 75:1995;2844-2852
21. Goldstein N.S., Mani A., Chmielewski G., et al. Prognostic factors in T1 N0 M0 adenocarcinomas and bronchioloalveolar carcinomas of the lung. Am J Clin Pathol. 112:1999;391-402
22. Suzuki K., Yokose T., Yoshida J., et al. Prognostic significance of the size of central fibrosis in peripheral adenocarcinoma of the lung. Ann Thorac Surg. 69:2000;893-897
23. Terasaki H., Niki T., Matsuno Y., et al. Lung adenocarcinoma with mixed bronchioloalveolar and invasive components. Clinicopathological features, subclassification by extent of invasive foci, and immunohistochemical characterization. Am J Surg Pathol. 27:2003;937-951
24. Zarbo R.J., Fenoglio-Preiser C. Interinstitutional database for comparison of performance in lung fine needle aspiration cytology. a College of American pathologists Q-probe study of 5264 cases with histologic correlation Arch Path Lab Med. 116:1992;463-470
25. Aida S., Shimazaki H., Sato K., et al. Prognostic significance of frequent acidophilic nuclear inclusions in adenocarcinoma of the lung with immunohistochemical and ultrastructural studies. Cancer. 91:2001;1896-1904
26. Chan C., Chan J.K. Can pulmonary sclerosing haemangioma be accurately diagnosed by intra-operative frozen section? Histopathol. 41:2002;392-403
27. Ishikawa A., Motohashi S., Shibuya K., et al. Small solitary pulmonary metastasis detected before primary sigmoid colon cancer. report of a case Surg Today. 33:2003;709-711
28. Flieder D.B. Screen-detected adenocarcinoma of the lung. Practical points for surgical pathologists. Am J Clin Pathol. 119:2003;s39-s57
29. Barbareschi M., Murer B., Colby T.V., et al. CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs. Am J Surg Pathol. 27:2003;141-149
30. Dabbs D.J., Landreneau R.J., Liu Y., et al. Detection of estrogen receptor by immunohistochemistry in pulmonary adenocarcinoma. Ann Thorac Surg. 73:2002;403-406
31. Satoh F., Umemura S., Osamura R.Y. Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue. Breast Cancer. 7:2000;49-55
32. Mountain C.F. Revisions in the international system for staging lung cancer. Chest. 111:1997;1710-1717
33. Okada M., Sakamoto T., Nishio W., et al. Characteristics and prognosis of patients after resection of nonsmall cell lung cancer measuring 2. cm or less in greatest dimension Cancer. 98:2003;535-541
34. Port J.L., Kent M.S., Korst R.J., et al. Tumor size predicts survival within stage IA non-small cell lung cancer. Chest. 124:2003;1828-1833
35. Battafarano R.J., Meyers B.F., Guthrie T.J., et al. Surgical resection of multifocal non-small cell lung cancer is associated with prolonged survival. Ann Thorac Surg. 74:2002;988-994
36. Roberts P.F., Straznicka M., Lara P.N., et al. Resection of multifocal non-small cell lung cancer when the bronchioloalveolar subtype is involved. J Thorac Cardiovasc Surg. 126:2003;1597-1602
37. Nicholson A.G., Graham A.N.J., Pezzella F., et al. Does the use of immunohistochemistry to identify micrometastases provide useful information in the staging of node-negative non-small cell lung carcinomas? Lung Cancer. 18:1997;231-240
38. Osaki T., Oyama T., Chun-Dong G., et al. Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage I non-small-cell lung cancer. J Clin Oncol. 20:2002;2930-2936
39. Marchevsky A.M., Qiao J.H., Krajisnik S., et al. The prognostic significance of intranodal isolated tumor cells and micrometastases in patients with non-small cell carcinoma of the lung. J Thorac Cardiovasc Surg. 126:2003;551-557
40. Liptay M.J., Grondin S.C., Fry W.A., et al. Intraoperative sentinel lymph node mapping in non-small cell lung cancer improves detection of micrometastases. J Clin Oncol. 20:2002;1984-1988
41. Brundage M.D., Davies D., Mackillop W.J. Prognostic factors in non-small cell lung cancer. A decade of progress. Chest. 122:2002;1037-1057
42. Massion P.P., Carbone D.P. The molecular basis of lung cancer. molecular abnormalities and therapeutic implications Respir Res. 4:2003;4-27
43. Gordon G.J., Richards W.G., Sugarbaker D.J., et al. A prognostic test for adenocarcinoma of the lung from gene expression profiling data. Cancer Epidemiol Biomarkers Prev. 12:2003;905-910
44. Ebright M.I., Zakowski M.F., Martin J., et al. Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma. Ann Thorac Surg. 74:2002;1640-1647
45. Martini N., Bains M.S., Burt M.E., et al. Incidence of local recurrence and second primaries in resected stage I lung cancer. J Thorac Cardiovasc Surg. 109:1995;120-129
46. Ginsberg R.J., Rubinstein L.V. Randomized trial of lobectomy versus limited resection for TI N0 non-small cell lung cancer. Ann Thorac Surg. 60:1995;615-623
47. Watanabe S., Watanabe T., Arai K., et al. Results of wedge resection for focal bronchioloalveolar carcinoma showing pure ground-glass attenuation on computed tomography. Ann Thorac Surg. 73:2002;1071-1075
48. Goldstein N.S., Ferkowicz M., Kestin L., et al. Wedge resection margin distances and residual adenocarcinoma in lobectomy specimens. Am J Clin Pathol. 120:2003;720-724